Abstract
Ronidazole (RNZ) is widely used for the therapeutic treatment of farmed animals and is suspected of being a human carcinogen and mutagen. The interaction between RNZ and human serum albumin (HSA) was investigated systematically by fluorescence spectroscopy, synchronous fluorescence, three-dimensional fluorescence, CD spectroscopy, UV–vis absorption spectroscopy and a molecular docking study. The results indicate that the probable quenching mechanism of HSA by RNZ is dynamic quenching. The corresponding thermodynamic parameters, such as ΔH, ΔS and ΔG, etc., were calculated according to the van’t Hoff equation. The results indicate that the forces acting between RNZ and HSA are mainly hydrogen bonds and van der Waals forces. The conformational changes in the interaction were studied by synchronous fluorescence, CD spectroscopy and three-dimensional fluorescence spectra. The results reveal that the microenvironment and conformation of HSA has been changed. A molecular modeling study further confirmed the binding mode obtained by the experimental studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
